Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma

Eisai

Status: Completed

Conditions: Hepatocellular Carcinoma

Treatments: Device: E7040

Study type: Observational

Funder types: Industry

Identifiers

NCT02269995

DCB01S

Details and patient eligibility

About

This surveillance's objectives are:

1. Unknown adverse reactions
2. Incidences of adverse drug reaction
3. Factors considered to have effect to safety and effectiveness

Enrollment: 300 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients with Hepatocellular carcinoma

Exclusion criteria

None

Trial design

300 participants in 1 patient group

E7040

Treatment:

Device: E7040